Navigation Links
ICUROS study finds international variations in quality of life loss after fracture
Date:3/24/2011

A study presented today at the European Congress on Osteoporosis and Osteoarthritis currently taking place in Valencia, Spain has found that the initial quality of life loss following an osteoporotic fracture is substantial, especially with regard to hip and vertebral fractures. The study found differences in quality of life loss between countries after correcting for other explanatory variables.

The quality of life (QoL) of patients who sustained a hip, wrist or vertebral fracture was examined for the four months following the fracture. The study is part of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS) which is an international patient-based study endorsed by the International Osteoporosis Foundation. ICUROS investigates the costs and health effects of osteoporotic fractures in women and men over the age of fifty. The aim is to gather better information regarding the burden of osteoporosis in the participating countries and worldwide. Currently, eleven countries are involved in ICUROS.

Involving 2,737 patients from nine countries, the study found that quality of life loss over four months was highest for hip fractures, followed by vertebral and wrist fractures. Interestingly, significant variations between countries were identified. Quality of life loss after hip fracture was greatest in Lithuania, followed by Italy, Russia and Mexico. Lower quality of life loss was experienced by hip fracture patients in Austria and Sweden. In all countries in which vertebral fractures were studied, patients who were hospitalized experienced more quality of life loss than those who were not hospitalized following vertebral fracture.


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. Children With Tourette Syndrome Have Better Motor Control, Study Finds
2. Americans Exposure to Mercury From Fish Wont Harm Hearts: Study
3. Even Mild Stress Can Lead to Disability, Study Says
4. Actos Cut Risk of Prediabetes Becoming Diabetes in Study
5. Menthol Cigarettes Pose No Added Lung Cancer Risk: Study
6. Mass. General study reveals how lung cancers evolve in response to targeted treatment
7. Sleep Less, Eat More: Study
8. Lung Cancer Evolves With Treatment, Study Finds
9. Long-term study: Robot-assisted prostate surgery is safe
10. Study: Infrequent Sex Can Raise Risk of Heart Attack, Death
11. UT MD Anderson receives grant for study of acupuncture in cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... ... It is vital for any lab to secure funding, and the best ... Beckman Coulter has designed Kaluza, templates with advanced analytical tools to streamline analysis and ... a GLP (Good Laboratory Practice) fashion. , With features designed to simplify life in ...
(Date:12/7/2016)... San Fernando Valley, CA (PRWEB) , ... December 07, 2016 , ... ... Sculptra can be used in several ways to restore a more youthful appearance to ... doctors , now offer Sculptra, along with a variety of other treatments, to rejuvenate ...
(Date:12/7/2016)... ... December 07, 2016 , ... A quote from Dr. Edward ... comments on social media that offer a rare glimpse into the mind of those ... and New York Times bestselling author, has described people with ADHD as having “Ferrari ...
(Date:12/7/2016)... ... December 07, 2016 , ... Levels of a protein in the blood associated ... appearing online in the journal Radiology. , Heart disease and brain disease exact a ... the rapidly aging population. Damage to both organs often occurs at a subclinical stage, ...
(Date:12/7/2016)... ... ... They are musicians and librarians, fashion designers and fitness instructors, actors, athletes and ... around the nation. What do they have in common? All have been affected by ... new photographic exhibit debuting Friday, December 9 at Logan International Airport in Boston. , ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... DIEGO , Dec. 6, 2016  Arcturus ... RNA medicines company, announced today that it entered ... develop RNA-based therapeutics for the treatment of NASH ... wholly-owned therapeutic delivery platform LUNAR™ and UNA Oligomer ... "Given Takeda,s long-standing commitment to and expertise ...
(Date:12/6/2016)... , Dec. 6, 2016  Regulus Therapeutics Inc. ... leading the discovery and development of innovative medicines ... candidates at its R&D day, held in ... RGLS5040, is an anti-miR targeting microRNA-27 (miR-27) for ... RGLS4326, is an anti-miR targeting microRNA-17 (miR-17) for ...
(Date:12/6/2016)... new study released today by the Alliance for Integrity ... Pricing Program will continue to expand at an unprecedented rate ... $23 billion in total purchases at the 340B price. This ... B drug reimbursement purchases over the next five years.      ... data on total drug purchases through 340B from 2005 to ...
Breaking Medicine Technology: